XML 36 R28.htm IDEA: XBRL DOCUMENT v3.25.2
Basis of Presentation and Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Fair Value Measurement Specific to Assets or Liability

 

Fair Value Measurements at Reporting Date Using (in thousands)

 

 

Balances as of
June 30, 2025

 

 

Quoted Prices in
Active Markets for
Identical
Assets/Liabilities
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable Inputs
(Level 3)

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

102,194

 

 

$

102,194

 

 

$

 

 

$

 

U.S. Treasuries

 

$

407,687

 

 

$

407,687

 

 

$

 

 

$

 

Investment in equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Equity securities

 

$

21,256

 

 

$

21,256

 

 

$

 

 

$

 

 

 

Fair Value Measurements at Reporting Date Using (in thousands)

 

 

Balances as of
December 31,
2024

 

 

Quoted Prices in
Active Markets for
Identical
Assets/Liabilities
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable Inputs
(Level 3)

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

109,947

 

 

$

109,947

 

 

$

 

 

$

 

U.S. Treasuries

 

$

329,457

 

 

$

329,457

 

 

$

 

 

$

 

Investment in equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Equity securities

 

$

21,564

 

 

$

21,564

 

 

$

 

 

$

 

Summary of Disaggregated Product Revenue

The following table summarizes the Company’s net product revenue disaggregated by product (in thousands):

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

FIRDAPSE®

 

$

84,845

 

 

$

77,372

 

 

$

168,576

 

 

$

144,214

 

FYCOMPA®

 

 

34,332

 

 

 

36,535

 

 

 

69,959

 

 

 

66,960

 

AGAMREE®*

 

 

27,363

 

 

 

8,746

 

 

 

49,405

 

 

 

9,920

 

Total product revenue, net

 

$

146,540

 

 

$

122,653

 

 

$

287,940

 

 

$

221,094

 

_________________

*AGAMREE® net product revenue for the six months ended June 30, 2024 is for the period between March 13, 2024 (date of commercial launch) and June 30, 2024.

Summary of Percentage of the Company's Total Net Product Revenue

The following table illustrates the approximate percentage of the Company’s total net product revenue attributed to the Company’s largest customers for the periods presented:

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Customer A

 

 

76.5

%

 

 

70.2

%

 

 

75.3

%

 

 

69.7

%

Customer B

 

 

8.5

%

 

 

11.2

%

 

 

9.1

%

 

 

10.4

%

Total

 

 

85.0

%

 

 

81.4

%

 

 

84.4

%

 

 

80.1

%

Basic and Dilutive Weighted Average Common Shares

The following table reconciles basic and diluted weighted average common shares:

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Basic weighted average common shares
   outstanding

 

 

122,163,212

 

 

 

118,180,396

 

 

 

121,819,748

 

 

 

117,493,257

 

Effect of dilutive securities

 

 

5,380,072

 

 

 

6,475,603

 

 

 

5,441,779

 

 

 

6,535,495

 

Diluted weighted average common shares
   outstanding

 

 

127,543,284

 

 

 

124,655,999

 

 

 

127,261,527

 

 

 

124,028,752

 

Schedule of Significant Segment Expenses of Stock-based Compensation

The following table illustrates information about significant segment expenses, inclusive of stock-based compensation:

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

4,358

 

 

$

2,985

 

 

$

8,245

 

 

$

5,566

 

Selling

 

 

31,133

 

 

 

28,100

 

 

 

63,233

 

 

 

55,098

 

General and administrative (a)

 

 

14,816

 

 

 

12,630

 

 

 

29,627

 

 

 

32,570

 

Total

 

$

50,307

 

 

$

43,715

 

 

$

101,105

 

 

$

93,234

 

__________________________________________

(a) exclusive of amortization of intangible assets